Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2001 | 06-2001 | 03-2001 | 12-2000 | 09-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,950 | -1,150 | -520 | -2,250 | -1,660 |
| Depreciation Amortization | 100 | 60 | 30 | 100 | 70 |
| Other Working Capital | 350 | 120 | 120 | 120 | 440 |
| Other Operating Activity | 100 | 110 | 50 | 220 | 100 |
| Operating Cash Flow | $-1,400 | $-860 | $-320 | $-1,810 | $-1,050 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -50 | -50 | -3 | -9 | -5 |
| Investing Cash Flow | $-50 | $-50 | $-3 | $-9 | $-5 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,510 | 1,040 | 790 | 1,750 | 1,150 |
| Financing Cash Flow | $1,510 | $1,040 | $790 | $1,750 | $1,150 |
| Beginning Cash Position | 140 | 140 | 140 | 210 | 210 |
| End Cash Position | 180 | 260 | 600 | 140 | 300 |
| Net Cash Flow | $40 | $120 | $460 | $-70 | $90 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,400 | -860 | -320 | -1,810 | -1,050 |
| Free Cash Flow | -1,400 | -860 | -320 | -1,810 | -1,050 |